Cabaletta Bio, Inc. (CABA) › Operating IncomeCabaletta Bio, Inc. (CABA) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2018: -$6.19M2019: -$18.68M2020: -$33.83M2021: -$46.31M2022: -$54.14M2023: -$74.66M2024: -$125.14M2025: -$172.24M-$172.24M2018Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$172.24M-37.6%2024-$125.14M-67.6%2023-$74.66M-37.9%2022-$54.14M-16.9%2021-$46.31M-36.9%2020-$33.83M-81.1%2019-$18.68M-201.7%2018-$6.19M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share